PlainRecalls
FDA Drug Low Class III Terminated

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Reported: March 27, 2024 Initiated: March 4, 2024 #D-0389-2024

Product Description

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Reason for Recall

Cross Contamination with Other Products:(mycophenolate mofetil).

Details

Recalling Firm
Novitium Pharma LLC
Units Affected
3,940 1000-count bottles
Distribution
Nationwide in the USA
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20. Recalled by Novitium Pharma LLC. Units affected: 3,940 1000-count bottles.
Why was this product recalled?
Cross Contamination with Other Products:(mycophenolate mofetil).
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2024. Severity: Low. Recall number: D-0389-2024.